• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [17988 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2021     Swiss Federal Office of Public Health (FOPH) The treatment of primary hypercholesterolaemia and mixed/combined hyperlipidaemia with ezetimibe-containing medicines
2021     Ontario Health Skin substitutes for adults with diabetic foot ulcers and venous leg ulcers
2021     Ontario Health Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression
2021     Swedish Agency for Health Technology Assessment and Assessment of Social Services (SBU) Screening for common mental disorders during pregnancy and for traumatic experiences after delivery
2021     Ontario Health Pigmented lesion assay for suspected melanoma lesions
2021     Norwegian Institute of Public Health (NIPH) [Liposuction (lipectomy) for the treatment of fat accumulation caused by chronic lymphoedema]
2021     Ontario Health Proton Beam Therapy for Cancer in Children and Adults: A Health Technology Assessment
2021     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of the SpaceOAR hydrogel rectal spacer during prostate radiotherapy]
2021     Center for Evidence-based Practice (CEP) COVID-19: mandatory vaccination
2021     Ontario Health Use of B-Type Natriuretic Peptide (BNP) and N-Terminal proBNP (NT-proBNP) as Diagnostic Tests in Adults With Suspected Heart Failure
2021     Ontario Health Vaginal pessaries for pelvic organ prolapse and stress urinary incontinence
2021     Scottish Medicines Consortium (SMC) Secukinumab for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs)
2021     Scottish Medicines Consortium (SMC) Brentuximab vedotin in combination with cyclophosphamide, doxorubicin and prednisone (CHP) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (sALCL)
2021     Scottish Medicines Consortium (SMC) Melatonin (Slenyto) for the treatment of insomnia in children and adolescents aged 2-18 with autism spectrum disorder (ASD) and / or Smith-Magenis syndrome, where sleep hygiene measures have been insufficient
2020     Technology Assessment at SickKids (TASK) Microcosting of whole genome sequencing (WGS) of trios in heterogeneous pediatric cardiac population
2020     Center for Evidence-based Practice (CEP) COVID-19: prophylactic use of hydroxychloroquine (HCQ)
2020     Center for Evidence-based Practice (CEP) COVID-19: treatment with hydroxychloroquine (HCQ)
2020     Center for Evidence-based Practice (CEP) COVID-19: infectivity of patients who have recovered from disease
2020     Center for Evidence-based Practice (CEP) Cytokine adsorption for treatment of COVID-19 disease
2020     Center for Evidence-based Practice (CEP) COVID-19: decontamination and reprocessing of personal protective equipment (PPE)
2020     Center for Evidence-based Practice (CEP) Transmission of respiratory infections via showers
2020     Center for Evidence-based Practice (CEP) Remdesivir for treatment of COVID-19 disease
2020     Center for Evidence-based Practice (CEP) COVID-19: sedation-ventilation liberation of COVID+ patients
2020     Center for Evidence-based Practice (CEP) COVID-19: surgical masks and filtering face piece respirators (FFR) for health care providers
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) Rapid collaborative review on the current role of antibody tests for novel coronavirus SARS-CoV-2 in the management of the pandemic
2020     Center for Evidence-based Practice (CEP) COVID-19: point-of-care (POC) testing
2020     Center for Evidence-based Practice (CEP) COVID-19: antibiotic management in ambulatory patients
2020     Center for Evidence-based Practice (CEP) COVID-19: temperature screening for healthcare personnel
2020     Andalusian Health Technology Assessment Area (AETSA) [C-Reactive Protein point-of-care testing (CRP-POCT) to guide antibiotic prescribing in primary care settings for acute respiratory tract infections]
2020     Center for Evidence-based Practice (CEP) COVID-19: criteria for discharging patients from inpatient care
2020     Norwegian Institute of Public Health (NIPH) Safety, clinical effectiveness, predictive accuracy and cost effectiveness of blood based tests for women with suspected preeclampsia: a health technology assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: high flow nasal cannula (HFNC)/non-invasive positive pressure ventilation (NIPPV) indications
2020     Center for Evidence-based Practice (CEP) COVID-19: proning considerations for patients on HFNC or BIPAP
2020     Center for Evidence-based Practice (CEP) COVID-19: criteria for advising home care patients to return to the hospital
2020     NIHR Health Services and Delivery Research programme Stroke Sentinel Audit Programme: Investigating and Evaluating Stroke Therapy (SSNAPIEST)
2020     Norwegian Institute of Public Health (NIPH) Intracoronary lithotripsy for the treatment of coronary artery disease: a health technology assessment
2020     Center for Evidence-based Practice (CEP) COVID-19: surge triage for suspected influenza-like illness
2020     NIHR Health Services and Delivery Research programme An evaluation of a multifaceted intervention to reduce antimicrobial prescribing in care home residents [REducing Antimicrobials in Care Homes (REACH)]: a non-randomised feasibility study and process evaluation
2020     Norwegian Institute of Public Health (NIPH) Disease modifying drugs for treatment of primary progressive multiple sclerosis: A health technology assessment
2020     NIHR Health Services and Delivery Research programme UK Study of tendon Achilles Rehabilitation multicentre randomised clinical trial (UK STAR)
2020     Institut national d'excellence en sante et en services sociaux (INESSS) [Optimal use guide: pharmacological treatment of sexually transmitted and blood-borne infections ─ infections caused by chlamydia trachomatis and neisseria gonorrhoeae]
2020     NIHR Health Technology Assessment programme Selective internal radiation therapies for unresectable early-, intermediate- or advanced-stage hepatocellular carcinoma: systematic review, network meta-analysis and economic evaluation
2020     NIHR Health Services and Delivery Research programme IMPlementation of A Relatives Toolkit (IMPART study): examining the critical success factors, barriers and facilitators to implementation of an online supported self-management intervention in the NHS
2020     NIHR Health Technology Assessment programme Lenvatinib and sorafenib for differentiated thyroid cancer after radioactive iodine: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2020     NIHR Health Technology Assessment programme Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation
2020     Austrian Institute for Health Technology Assessment (AIHTA) Proton and carbon ion therapy - an update on indications
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Endovascular treatment of varicose veins by radiofrequency ablation or cyanoacrylate closure]
2020     NIHR Health Technology Assessment programme Oral splints for patients with temporomandibular disorders or bruxism: a systematic review and economic evaluation
2020     NIHR Health Technology Assessment programme Interventions to reduce the risk of surgically transmitted Creutzfeldt–Jakob disease: a cost-effective modelling review
2020     Malaysian Health Technology Assessment (MaHTAS) Pre-dialysis education programme (PDEP)
2020     Malaysian Health Technology Assessment (MaHTAS) Diagnostic approaches to solitary pulmonary nodule (SPN)
2020     Malaysian Health Technology Assessment (MaHTAS) Cinacalcet for the treatment of secondary hyperparathyroidism in end stage renal failure and economic evaluation
2020     Malaysian Health Technology Assessment (MaHTAS) Influenza vaccination for the elderly and economic evaluation
2020     Swiss Federal Office of Public Health (FOPH) Olmesartan Mono- and Combination Therapies in Patients with Essential Hypertension
2020     Malaysian Health Technology Assessment (MaHTAS) Intravenous iron for iron deficiency anaemia
2020     Swiss Federal Office of Public Health (FOPH) Treatment of non-erosive gastroesophageal reflux disease patients with proton pump inhibitors
2020     Malaysian Health Technology Assessment (MaHTAS) Programmatic management of latent tuberculosis infection
2020     Swiss Federal Office of Public Health (FOPH) Chondroitin Sulfate in Osteoarthritis
2020     Malaysian Health Technology Assessment (MaHTAS) Automatic guided vehicles (AGVs) for transportation of food and materials in hospitals
2020     Malaysian Health Technology Assessment (MaHTAS) Digital dental impression
2020     Malaysian Health Technology Assessment (MaHTAS) Biocompatible peritoneal dialysis (PD) solution
2020     Swiss Federal Office of Public Health (FOPH) Iron Therapy for Iron Deficiency without Anemia
2020     Health Technology Wales (HTW) Autologous haematopoietic stem cell transplantation for previously treated, relapsing-remitting multiple sclerosis
2020     Health Technology Wales (HTW) Pre-operative cardiopulmonary exercise testing for people in whom major abdominal surgery is planned
2020     Health Technology Wales (HTW) Rapid antigen detecting tests for diagnosing group A streptococcal infections in the community pharmacy setting
2020     Health Technology Wales (HTW) Transcatheter aortic valve implantation (TAVI) for the treatment of patients with severe symptomatic aortic stenosis who are at intermediate surgical risk
2020     Health Technology Wales (HTW) Point of care haemolysis detection in blood samples that may be deemed unfit for laboratory analysis
2020     NIHR Health Technology Assessment programme Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis
2020     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of the left ventricular assist device (LVAD) as destination therapy in paediatric patients]
2020     NIHR Health Services and Delivery Research programme The effects of interoperable information technology networks on patient safety: a realist synthesis
2020     European Network for Health Technology Assessment (EUnetHTA) Rolling Collaborative Review COVID-19 - Lopinavir + Ritonavir
2020     NIHR Health Services and Delivery Research programme Social norms interventions to change clinical behaviour in health workers: a systematic review and meta-analysis
2020     Belgian Health Care Knowledge Centre (KCE) Polyvalent immunoglobulins – Part 2: use in Belgium
2020     Malaysian Health Technology Assessment (MaHTAS) Prophylactic anticoagulation in ambulatory cancer patients
2020     Norwegian Institute of Public Health (NIPH) [Intermittent pneumatic compression for preventing deep vein thrombosis in acute stroke, a health technology assessment]
2020     Malaysian Health Technology Assessment (MaHTAS) Antifibrotic for treatment of idiopathic pulmonary fibrosis
2020     Norwegian Institute of Public Health (NIPH) [Effectiveness of microwave thermotherapy (TUMT) compared to transurethral resection of the prostate (TURP) for benign prostatic hyperplasia]
2020     Malaysian Health Technology Assessment (MaHTAS) Needleless Vacutainer system for blood collection
2020     NIHR Health Services and Delivery Research programme Variations in the organisation of Early Pregnancy Assessment Units (EPAUs) in the UK and their effects on clinical, service and patient-centred outcomes (VESPA)
2020     NIHR Health Technology Assessment programme Rapid antigen detection and molecular tests for group A streptococcal infections for acute sore throat: systematic reviews and economic evaluation
2020     National Committee for Technology Incorporation (CONITEC) [Dolutegravir for the treatment of pregnant women living with HIV]
2020     National Committee for Technology Incorporation (CONITEC) [Baricitinib (Olumiant) for patients with moderate to severe active rheumatoid arthritis]
2020     NIHR Health Technology Assessment programme A systematic review of psychological interventions to improve motivation for self-management in people with type 1 and type 2 diabetes
2020     National Committee for Technology Incorporation (CONITEC) [Mirabegron for the treatment of storage dysfunction in patients with neurogenic bladder]
2020     NIHR Health Services and Delivery Research programme Using co-production to improve patient carer and staff experiences in health care organizations: a multi-centre, mixed methods evaluation in inpatient stroke units (CREATE)
2020     National Committee for Technology Incorporation (CONITEC) [Antimuscarinics (oxybutynin, tolterodine, solifenacin and darifenacin) for the treatment of storage dysfunction in patients with neurogenic bladder]
2020     National Committee for Technology Incorporation (CONITEC) [Photodynamic therapy for non-melanoma skin cancer]
2020     National Committee for Technology Incorporation (CONITEC) [Newborn screening for congenital toxoplasmosis]
2020     NIHR Public Health Research (PHR) programme A woman-centred, tailored SMS-delivered multi-component intervention for weight loss and maintenance of weight loss in the postpartum period: intervention adaptation and pilot RCT
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Brigatinib (non-small cell lung cancer) - Addendum to Commission A20-42]
2020     National Committee for Technology Incorporation (CONITEC) [Riociguat for inoperable or persistent/recurrent chronic thromboembolic pulmonary hypertension after surgical treatment]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Ozanimod (relapsing remitting multiple sclerosis) - Benefit assessment according to §35a Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Orlistat for weight loss in overweight or obese patients]
2020     NIHR Public Health Research (PHR) programme A two arm feasibility trial of lifestyle information and Slimming World groups to promote weight management and positive lifestyle behaviour in postnatal women from an ethnically diverse inner city population
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Caplacizumab (acquired thrombotic thrombocytopenic purpura) - Assessment according to §35a (1), Sentence 11, Social Code Book V]
2020     National Committee for Technology Incorporation (CONITEC) [Sibutramine for the treatment of obese patients]
2020     Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Venetoclax (chronic lymphocytic leukaemia) - Addendum to Commission A20-39]
2020     National Committee for Technology Incorporation (CONITEC) [Empagliflozin and dapagliflozin for the treatment of type 2 diabetes mellitus]